INSULIN RESISTANCE AND A RISK FOR POOR OUTCOME ONE YEAR AFTER MYOCARDIAL INFARCTION
- Authors: Gruzdeva O.1, Karetnikova V.1, Uchasova E.1, Kuzmina A.1, Kashtalap V.1, Barbarash O.1
-
Affiliations:
- Research Institute for Complex Problems of Cardiovascular Diseases
- Issue: Vol 26, No 12 (2015)
- Pages: 30-34
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/116406
- ID: 116406
Cite item
Open Access
Access granted
Abstract
Keywords
Full Text
About the authors
O. Gruzdeva
Research Institute for Complex Problems of Cardiovascular Diseases
Email: gruzov@cardio.kem.ru
V. Karetnikova
Research Institute for Complex Problems of Cardiovascular Diseases
E. Uchasova
Research Institute for Complex Problems of Cardiovascular Diseases
A. Kuzmina
Research Institute for Complex Problems of Cardiovascular Diseases
V. Kashtalap
Research Institute for Complex Problems of Cardiovascular Diseases
O. Barbarash
Research Institute for Complex Problems of Cardiovascular Diseases
References
- Rydén L., Grant P., Anker S. et al. Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention // Eur. J. Anaesthesiol. - 2009; 26: 856-62.
- Sattar N. Insulin resistance and the metabolic syndrome as predictors of cardiovascular risk: where are we now? // Minerva Endocrinol. - 2005; 3 (3): 121-38.
- Cefalu W. Exp. Insulin resistance: cellular and clinical concepts // Biol. Med. - 2001; 226: 13-26.
- Collet J., Montalescot G., Vicaut E. et al. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality // Circulation. - 2003; 108: 391-4.
- Gruzdeva O., Uchasova E., Belik E. et al. Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance // BMC Cardiovasc. Disord. - 2014; 14: 7.
- Барбараш О.Л., Груздева О.В., Акбашева О.Е. и др. Манифестация сахарного диабета второго типа как позднее осложнение инфаркта миокарда // Рос. кардиол. журн. - 2014; 3 (107): 87-94.
- De Fronzo R., Abdul-Ghani M. Type 2 diabetes can be prevented with early pharmacological intervention // Diabetes Care. - 2011; 34 (2): 202-29.
- Каретникова В.Н. Маркеры неблагоприятного прогноза у больных острым инфарктом миокарда с подъемом сегмента ST в сочетании с нарушениями углеводного обмена. Автореф. дис.. д-ра мед. наук. Кемерово, 2010.
- Katz A., Nambi S., Mather K. et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans // J. Clin. Endocrinol. Metab. - 2000; 85: 2402-10.
- Stubbs P., Alaghband-Zadeh J., Laycock J. Significance of an index of insulin resistance on admission in non-diabetic patients with acute coronary syndromes // Heart. - 1999; 82 (4): 443-7.
- Garcia R., Rincön M., Arenas W. et al. Hyperinsulinemia is a predictor of new cardiovascular events in Colombian patients with a first myocardial infarction // Int. J. Cardiol. - 2011; 148 (1): 85-90.
- Grossman A., Opie L., Beshansky J. et al. Glucose-insulin-potassium revived: current status in acute coronary syndromes and the energy-depleted heart // Circulation. - 2013; 127 (9): 1040-8.
Supplementary files
